Shanghai Shen Lian Biomedical Corporation (688098.SS)

CNY 5.89

(0.68%)

Market Cap (In CNY)

2.41 Billion

Revenue (In CNY)

301.48 Million

Net Income (In CNY)

31.51 Million

Avg. Volume

1.54 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.63-7.63
PE
-
EPS
-
Beta Value
0.693
ISIN
CNE100003P17
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Dongsheng Nie
Employee Count
-
Website
https://www.slbio.com.cn
Ipo Date
2019-10-28
Details
Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China.